738 related articles for article (PubMed ID: 34457120)
21. Maresin 1 protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting macrophage pyroptosis and inflammatory response.
Yang W; Tao K; Zhang P; Chen X; Sun X; Li R
Biochem Pharmacol; 2022 Jan; 195():114863. PubMed ID: 34861244
[TBL] [Abstract][Full Text] [Related]
22. Propofol attenuates inflammatory response and apoptosis to protect d-galactosamine/lipopolysaccharide induced acute liver injury via regulating TLR4/NF-κB/NLRP3 pathway.
Zhang Z; Tian L; Jiang K
Int Immunopharmacol; 2019 Dec; 77():105974. PubMed ID: 31735662
[TBL] [Abstract][Full Text] [Related]
23. The antagonistic effect of tamoxifen against d-galactosamine/lipopolysaccharide-induced acute liver failure is associated with reactivation of hepatic nuclear factor-κB.
Liu L; Zhao Y; Lin Y; Zhang R; Luo S; Ye P; Luo M
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):192-198. PubMed ID: 30721100
[No Abstract] [Full Text] [Related]
24. Avicularin alleviates acute liver failure by regulation of the TLR4/MyD88/NF-κB and Nrf2/HO-1/GPX4 pathways to reduce inflammation and ferroptosis.
Shi P; Zhu W; Fu J; Liang A; Zheng T; Wen Z; Wu X; Peng Y; Yuan S; Wu X
J Cell Mol Med; 2023 Nov; 27(21):3326-3338. PubMed ID: 37644784
[TBL] [Abstract][Full Text] [Related]
25. Nrf2 signaling and autophagy are complementary in protecting lipopolysaccharide/d-galactosamine-induced acute liver injury by licochalcone A.
Lv H; Yang H; Wang Z; Feng H; Deng X; Cheng G; Ci X
Cell Death Dis; 2019 Apr; 10(4):313. PubMed ID: 30952839
[TBL] [Abstract][Full Text] [Related]
26. Endoplasmic reticulum stress-activated glycogen synthase kinase 3β aggravates liver inflammation and hepatotoxicity in mice with acute liver failure.
Ren F; Zhou L; Zhang X; Wen T; Shi H; Xie B; Li Z; Chen D; Wang Z; Duan Z
Inflammation; 2015; 38(3):1151-65. PubMed ID: 25630719
[TBL] [Abstract][Full Text] [Related]
27. Cystathionine γ-lyase deficiency protects mice from galactosamine/lipopolysaccharide-induced acute liver failure.
Shirozu K; Tokuda K; Marutani E; Lefer D; Wang R; Ichinose F
Antioxid Redox Signal; 2014 Jan; 20(2):204-16. PubMed ID: 23758073
[TBL] [Abstract][Full Text] [Related]
28. Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway.
Pan CW; Yang SX; Pan ZZ; Zheng B; Wang JZ; Lu GR; Xue ZX; Xu CL
Oncotarget; 2017 Jun; 8(25):41202-41210. PubMed ID: 28465482
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of UII/UTR system relieves acute inflammation of liver through preventing activation of NF-κB pathway in ALF mice.
Liang DY; Liu LM; Ye CG; Zhao L; Yu FP; Gao DY; Wang YY; Yang ZW; Wang YY
PLoS One; 2014; 8(6):e64895. PubMed ID: 23755157
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of morin on lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting TLR4/NF-κB and activating Nrf2/HO-1 signaling pathways.
Tian Y; Li Z; Shen B; Zhang Q; Feng H
Int Immunopharmacol; 2017 Apr; 45():148-155. PubMed ID: 28213269
[TBL] [Abstract][Full Text] [Related]
31. Qingchangligan formula attenuates the inflammatory response to protect the liver from acute failure induced by d-galactosamine/lipopolysaccharide in mice.
Zhang X; Ding J; Gou C; Wen T; Li L; Wang X; Yang H; Liu D; Lou J; Chen D; Ren F; Li X
J Ethnopharmacol; 2017 Apr; 201():108-116. PubMed ID: 27833028
[TBL] [Abstract][Full Text] [Related]
32. Geraniol protects against lipopolysaccharide and D-galactosamine-induced fulminant hepatic failure by activating PPARγ.
Li Y; Wang N; Jiang Y
Microb Pathog; 2019 Mar; 128():7-12. PubMed ID: 30550845
[TBL] [Abstract][Full Text] [Related]
33. Ellagic acid protects Lipopolysaccharide/D-galactosamine-induced acute hepatic injury in mice.
Gu L; Deng WS; Liu Y; Jiang CH; Sun LC; Sun XF; Xu Q; Zhou H
Int Immunopharmacol; 2014 Oct; 22(2):341-5. PubMed ID: 25038320
[TBL] [Abstract][Full Text] [Related]
34. Naringenin affords protection against lipopolysaccharide/D-galactosamine-induced acute liver failure: Role of autophagy.
Ahmedy OA; Salem HH; Sayed NH; Ibrahim SM
Arch Biochem Biophys; 2022 Mar; 717():109121. PubMed ID: 35065059
[TBL] [Abstract][Full Text] [Related]
35. Protective effect of tormentic acid from Potentilla chinensis against lipopolysaccharide/D-galactosamine induced fulminant hepatic failure in mice.
Lin X; Zhang S; Huang R; Tan S; Liang S; Wu X; Zhuo L; Huang Q
Int Immunopharmacol; 2014 Apr; 19(2):365-72. PubMed ID: 24560903
[TBL] [Abstract][Full Text] [Related]
36. NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1.
Kim SJ; Lee SM
Free Radic Biol Med; 2013 Dec; 65():997-1004. PubMed ID: 23994575
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway.
Tao YC; Wang ML; Wu DB; Luo C; Tang H; Chen EQ
J Transl Med; 2019 May; 17(1):151. PubMed ID: 31077206
[TBL] [Abstract][Full Text] [Related]
38. Scoparone attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice.
Kang JW; Kim DW; Choi JS; Kim YS; Lee SM
Food Chem Toxicol; 2013 Jul; 57():132-9. PubMed ID: 23535186
[TBL] [Abstract][Full Text] [Related]
39. Curcumin attenuates lipopolysaccharide/d-galactosamine-induced acute liver injury by activating Nrf2 nuclear translocation and inhibiting NF-kB activation.
Xie YL; Chu JG; Jian XM; Dong JZ; Wang LP; Li GX; Yang NB
Biomed Pharmacother; 2017 Jul; 91():70-77. PubMed ID: 28448872
[TBL] [Abstract][Full Text] [Related]
40. Hepatoprotective effects of erythropoietin on D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.
Yang XF; He Y; Li HY; Liu X; Chen H; Liu JB; Ji WJ; Wang B; Chen LN
Mol Med Rep; 2014 Jul; 10(1):555-9. PubMed ID: 24788561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
